Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.The US Food and Drug Administration (FDA) has approved Innopharma's levetiracetam injection's abbreviated new drug application (ANDA).
Subscribe to our email newsletter
Levetiracetam Injection is indicated as adjunctive therapy in the treatment of partial onset seizures in adults with epilepsy.
Innopharma’s levetiracetam injection is the generic version of UCB’s Keppra injection.
Furthermore, the company has signed a licensing deal with X-GEN Pharmaceuticals to market and distribute levetiracetam injection in the US.
Innopharma is engaged in developing niche generic and specialty pharmaceutical products.